[This review was originally posted at the Nieman Journalism Lab Retin A Price, on Aug. 6, 2010.]
A newbie owner for Newsweek: This week was a big one for Newsweek: After being on the block since May, it was sold to Sidney Harman, a 92-year-old audio equipment mogul who's married to a Democratic congresswoman and owns no other media properties. The price: $1, plus the responsibility for Newsweek's liabilities, estimated at about $70 million, Retin A australia, uk, us, usa. The magazine's editor, Jon Meacham, is leaving with the sale, though he told Yahoo's Michael Calderone that he had decided in June to leave when Newsweek was sold, no matter who the new owners were. Harman's age and background and the low sale price made for quite a few biting jokes about the sale on Twitter, dutifully chronicled for us by Slate's Jack Shafer. Retin A forum, Harman didn't help himself out much by telling The New York Times he doesn't have a plan for Newsweek. In a pair of sharp articles, The Daily Beast painted a grim picture of what exactly Harman's getting himself into: The magazine's revenue dropped 38 percent from 2007 to 2009, and it's losing money in all of its core areas, Retin A Price. The Beast noted that with no other media properties, Harman doesn't have the synergy potential that the magazine's previous owners, The Washington Post Co., said Newsweek would need. So why was he chosen. Apparently, he genuinely cares about the publication, Retin A dose, and he's planning the least number of layoffs. (That, and the other bidders weren't too attractive, either.) PaidContent reported that his primary goal is to bring the magazine back to stability while he sets up a succession plan.
Everybody has ideas of what Harman should do with his newest plaything: MarketWatch's Jon Friedman wants to see Retin A Price, Newsweek drop the opinion-and-analysis approach that it's been aping from The Economist, as do several of the observers Politico talked to. (DailyFinance's Jeff Bercovici just wants Harman to make it a little less excruciatingly dull to read.) Two other Politico sources — new media guru Jeff Jarvis and former Newsweek Tumblr wizard Mark Coatney — want to see Newsweek shift away from a print focus and figure out how to be vital on the web. Media consultant Ken Doctor proposes pushing forward on tablet editions, Retin A pharmacy, multimedia and interacting with readers online as the future of the magazine. Jarvis also has some pieces of advice for magazines in general, urging to them to resist the iPad's siren song and get local, among other things.
Poynter's Rick Edmonds has the most intriguing idea for a new Newsweek — going nonprofit. That would likely require refining its editorial mission to a narrower focus on national and international affairs, with the pop culture analysis getting cut out, Edmonds says, but he believes Harman might actually be considering a nonprofit approach, Retin A Price. Ken Doctor suggests that with Harman's statements about the relative unimportance of turning a profit from the magazine, he's already blurring the lines between a for-profit and nonprofit organization.
Meanwhile, Retin A alternatives, others were busy speculating about who might be the editor to lead Newsweek into its next incarnation. Names thrown out included Newsweek International editor Fareed Zakaria, Newsweek.com editor Mark Miller, Slate Group editor Jacob Weisberg, and former Time editor and CNN CEO Walter Isaacson, Get Retin A, though Isaacson has taken himself out of consideration.
WikiLeaks and the need for context: WikiLeaks continued to see fallout from its unprecedented leak of 92,000 documents about the war in Afghanistan two weekends ago, with more cries for it to be shut down and its founder, Julian Assange, arrested, largely because its leak revealed the names of numerous Afghan informants to the U.S. Assange expressed regret Retin A Price, for those disclosures, and WikiLeaks said it's even asking for the Pentagon's help in identifying and redacting names of informants in its next document dump, though the Pentagon said they haven't heard from WikiLeaks yet. Not that the U.S, Retin A class. government hasn't been trying to make contact — it demanded the documents be returned(!), and agents detained a WikiLeaks researcher at customs and then tried to talk with him again at a hacking conference this week. An Australian TV station gave a fascinating inside look at Assange's life on the run, and Slate's Jack Shafer contrasted Assange's approach to leaking sensitive documents with the more government-friendly tack of traditional media outlets. WikiLeaks also had some news to report on the business-model side: It will begin collecting online micropayment donations through Flattr.
The ongoing discussion around WikiLeaks this week centered on what to do with the data it released, Retin A Price. The Tyndall Report provided a thorough roundup of how TV news organizations responded to the leak, Purchase Retin A, and several others pinned the rather ho-hum public reaction to the documents' contents on a lack of context provided by news organizations. Former Salon editor Scott Rosenberg said the leak provides a new opportunity to shed an antiquated scoop-based definition of news and bring the reality of the war home to people. In a smart post musing on the structure of the modern news story, the Lab's Megan Garber proposed an outlet dedicated solely to follow-up journalism, arguing that one of the biggest challenges in modern journalism is giving a sense of continuity to long-running stories. "What results is a flattening: the stories of our day, big and small, silly and significant, Retin A gel, ointment, cream, pill, spray, continuous-release, extended-release, are leveled to the same plane, occupying the same space, essentially, in the wobbly little IKEA bookshelf that is the modular news bundle," she wrote in a follow-up post.
Mashable also examined Retin A Price, (in nifty infographic form!) how WikiLeaks changes the whistleblower-journalist relationship, while NPR wondered whether WikiLeaks is on the source or journalist side of equation. And PBS' Idea Lab had something handy for news orgs: A guide to helping them think about how to handle large-scale document releases. Where can i find Retin A online, —
Tumblr trends upward: The social blogging service Tumblr got the New York Times profile treatment this week, as the paper focused on its growing popularity among news organizations who are trying to jump on it as the next big social media trend — a form of communication somewhere between Twitter and blogging. The article noted that several prominent media brands have Tumblr accounts, though many of them aren't doing much with theirs. Over at Mediaite, Anthony De Rosa, who runs the Tumblr account for the sports blog network SB Nation, said we can expect to see still more media outlets jump on the Tumblr bandwagon, buy Retin A no prescription, especially because it rewards smart media companies who have a distinctive voice.
New York's Nitasha Tiku tried to douse the hype, arguing that Mark Coatney's often-mentioned Tumblr success for Newsweek "wasn't thanks to the distribution channel on Tumblr, it was his irreverent, conversational style — and that will be difficult for the fresh-faced interns that old-media publications don't pay to run their Tumblrs." And Gawker gave us a graded rundown of traditional news orgs' Tumblr accounts, Retin A Price.
Two Internet freedom scares: From The Wall Street Journal and The New York Times this week came two stories that have had many people concerned about issues of freedom and the web. First, the Journal ran a series on the alarming amount of your online data and behavior that companies track on behalf of advertisers. Cluetrain Manifesto co-author Doc Searls argued that while the long-held ideal of intensely personal advertising is getting closer to reality, "the advertising business is going to crash up against a harsh fact: 'consumers' are real people, Real brand Retin A online, and most real people are creeped out by this stuff." Jeff Jarvis was much less moved by the Journal's reporting, mocking it as scaremongering that tells us nothing new. Salon's Dan Gillmor fell closer to Searls' outrage than to Jarvis' nonchalance, and media consultant Judy Sims said this series is a window into a complex future for display advertising, one that media executives need to become familiar with in a hurry. Retin A Price, Second, the Times unleashed an avalanche of commentary in the tech world with a report that Google and Verizon are moving toward an agreement that would allow companies to pay to get their content to web users more quickly, which would effectively end the passionately held open-Internet principle known as net neutrality. The FCC quickly suspended its closed-door net neutrality meetings, and despite denials from Google and Verizon (which Wired picked apart), a whole lot of whither-the-Internet concernensued, cheap Retin A no rx. I'm not going to dig too deeply into this story here (I'd rather wait until we have something concrete to opine about), but here are the best quick guides to what this might mean: J-prof Dan Kennedy, Salon's Dan Gillmor and ProPublica's Marian Wang.
Reading roundup: Just a couple of quick items this week:
— Thanks to Poynter, we got glimpses of a couple of softer paid-content options being tried out by GlobalPost and The Spokesman-Review of Spokane, Washington, Retin A images, that might be sprouting up soon elsewhere, too. The Lab's Megan Garber profiled one of the new companies offering that type of porous paywall, MediaPass, and All Things Digital's Peter Kafka sifted through survey results to try to divine what The New York Times' paywall might look like.
— Google's social media platform Google Wave officially died this week, a little more than a year after it was born. Tech pioneer Dave Winer looked at why it never took off and drew a few lessons, about Retin A, too.
— Finally, the Lab's Jonathan Stray took a look at some very cool things that The Guardian is doing with data journalism using free web-based tools. It's a great case study in a blossoming area of journalism.
Similar posts: Glucophage Dosage. Lipitor Mg. Glucophage No Rx. Effects of Lipitor. Where can i order Retin A without prescription. Flagyl photos.
Trackbacks from: Retin A Price. Retin A Price. Retin A Price. Retin A dose. Retin A cost. Buy Retin A from canada.
[This review was originally posted at the Nieman Journalism Lab Synthroid Price, on June 11, 2010.]
The Times has the Pulse (briefly) pulled: Last week, I noted one of the more interesting iPad news apps: The Pulse Reader, designed by two Stanford grad students, is a stylish news aggregator. But on Monday, the app was pulled from the iTunes store based on a claim that it infringes on The New York Times' copyright after some Times folks saw the paper's own blog post about the reader. The app was reinstated the next day, but the debate over copyright, aggregation and mobile apps had already taken off.
The central point of the Times' argument was that the $3.99 app was an illegal attempt to make money off of the Times' (and the Boston Globe's) free, publicly available RSS feeds, rx free Synthroid. (The paper also objected to app's placement of the Times' content within a frame on the iPad.) The Citizen Media Law Project's Kimberley Isbell helpfully broke down the Times' claims and the Pulse Reader's possible fair-use defenses, noting the Times articles' free accessibility and the relatively small article portions displayed on the reader.
Reaction on the web weighed overwhelmingly against the Times: Wired contended that every piece of paid software used to access the Times' site would be outlawed by the paper's logic, while Techdirt's Mike Masnick argued that Pulse was selling its software, not the Times' feeds, Synthroid Price. GigaOm's Mathew Ingram wondered whether the Times was declaring war on news aggregators, and the Sydney Morning Herald reasoned that if the Times is offering its RSS for free, it can't complain when someone designs a reader to view it. Blogging and RSS vet Dave Winer had the harshest response in a post arguing that the Times is in the business of news production, Fast shipping Synthroid, not distribution: "Look, if the Times is depending on stopping those two kids for its future, then the Times has no future."
The reader's creators were just as baffled as anybody about why the app was reinstated, a Times' spokesman apparently tried to pass off the complaint as a mistake, though that response doesn't exactly square with the Times' Martin Nisenholtz's reiteration of the paper's case to paidContent's Staci Kramer. As for whether this claim would apply beyond the Pulse Reader, Nisenholtz said it would be handled "on a case by case basis."
We had plenty of other iPad news this week, too — Jobs made a number of mostly iPhone-related announcements at a conference on Monday, Synthroid recreational, and the Lab's Josh Benton explained what they mean for mobile news. A few highlights: Apple's not too concerned about app-banning controversies, but it is moving decisively on ebooks and its iAd mobile advertising platform. The AP reported that publishers are seeing encouraging early signs Synthroid Price, about wringing advertising dollars out of the iPad, but Ken Doctor went on a wonderful little rant against publishers that are slow to take advantage of the iPad's capabilities. Meanwhile, the Wall Street Journal's Robert Thomson slammed news orgs' repurposed "crapps" and talked, with the Journal's Les Hinton, Buy cheap Synthroid, about his paper's own iPad strategy. And the iPad faced its first major security issue, as the email addresses of its 114,000 owners were exposed by hackers.
The purpose of the link: A Nicholas Carr post last week ignited a spirited discussion about the relative values of the link, and that conversation continued this week with twin Wall Street Journal columns by Carr and web scholar Clay Shirky debating whether the Internet makes us smarter. Carr said no, using a similar argument to the one he laid out in his earlier post (it's also the central point of his new book): The Internet encourages multitasking and bite-size information, making us all "scattered and superficial thinkers."Shirky said yes, Synthroid without prescription, arguing that the Internet enables never-before-experienced publishing and connective capabilities that allow us to put our cognitive surplus to work for a better society. (That's also the central point of his new book.) Quite a few people, led by GigaOm's Mathew Ingram, posited that both writers were right - Carr in the short term, Shirky in the long term.
Here at the Lab, Jason Fry weighed in on the delinkification debate, giving a useful classification of the link's primary purposes — credibility, readability and connectivity, Synthroid Price. Credibility has become a vital function in today's web, Synthroid for sale, Fry said, though he conceded Carr's point that the link adds to the cognitive load when it comes to readability. Based on Carr's original post, the web design firm Arc90 added an option to its browser extension to convert hyperlinks to footnotes.
The Lab also ran a fantastic three-part series on links by Jonathan Stray exploring four journalistic purposes of the hyperlink (it's essential, he says), examining the way news organizations talk about links (they're a bit muddled) and studying how much those news organizations actually link (not a whole lot, especially the wire services), Synthroid trusted pharmacy reviews. It's a tremendously helpful resource for anyone interested in looking at how linking and journalism intersect.
Debate over Newsweek's bidders: We found out about three bidders for Newsweek Synthroid Price, last Thursday, so last Friday was the time for profiles and commentary, much of it centered on the conservative news site and magazine Newsmax. Newsmax's CEO, Christopher Ruddy, told the Washington Post that it has a number of non-conservative media projects, so Newsweek wouldn't have to adopt a conservative viewpoint to be part of Newsmax's plans. "Newsmax's success is in its business model, Synthroid dose, not just its editorial approach," Ruddy said. Newsweek employees were worried about the prospect of a Newsmax-owned Newsweek, but the New York Times' Ross Douthat, himself a conservative, said Newsmax's influence could be just the nudge Newsweek needs to hit its sweet spot in America's heartland. Chicago magazine profiled another bidder, venture capitalist Thane Ritchie, Synthroid pics, while the Washington Post reported that audio equipment exec Sidney Harman is considering a bid, too.
Washington Post media critic Howard Kurtz devoted a column to the publicly acknowledged bidders, exploring the question of why no major players have emerged as bidders and concluding that the lack of interest "amounts to a no-confidence vote not just on the category of newsweeklies, which have long been squeezed between daily papers and in-depth monthlies, but on print journalism itself." Newsweek, via its Tumblr, ripped apart the work of its Washington Post Co, Synthroid Price. colleague, taking to task for a lack of evidence and disputing his claim that the re-envisioned Newsweek is a flop. (That Tumblr is written by Newsweek social-media guru David Coatney, who got a New York Daily Intel Q&A a couple of days later.) Meanwhile, Synthroid natural, New York Times columnist David Carr proposed eight ways to revive Newsweek.
A sports blog network goes local: ESPN has been making a well-documented and initially successful local sports media play over the past year, but this week, a very different sports media company is making a push into what used to be local newspapers' territory. SB Nation, a network of more than 250 fan-run sports blogs founded in 2003 by Tyler Bleszinski and Daily Kos' Markos Moulitsas Zuniga, began rolling out 20 city-specific sports media hubs. Synthroid Price, Until now, the company has focused on team-specific (or sport-specific, in the case of some less prominent sports) blogs, but the new sites will aggregate real-time sports news mixed with fan-generated conversation and commentary.
In a New York Times feature, generic Synthroid, SB Nation's Jim Bankoff said that while his company is trying to provide a ground-up alternative to traditional sports coverage, he'd be happy to collaborate with local newspapers. Former ESPN.com columnist Dan Shanoff echoed that perspective, saying that SB Nation's brand of sharp fan analysis is ripe for media partnerships because "it is something that local newspapers and local cable-sports networks can't or won't do well." Shanoff proposed that SB Nation become a piece of a larger media company's local media strategy, suggesting Comcast as an ideal fit.
Here at the Lab, Is Synthroid addictive, Bankoff gave Laura McGann a handful of lessons media organizations could learn from the SB Nation model, including tightly focused subject matter and maximizing repeat visitors. SB Nation's team-specific focus seems to be a major component in its success, and could have some ready implications for news organizations, as Bankoff noted: “We’re not fans of sports — we’re fans of teams. We’re not fans of television, Synthroid Price. We’re fans of shows.”
Reading roundup: This week, I've got two news items, a few interesting pieces of commentary and one set of tips, purchase Synthroid online no prescription.
— Advertising Age reported that AOL is planning to hire hundreds of journalists for a major expansion into news production. At the local media blog Lost Remote, Cory Bergman, who owns a local news network himself, noted that AOL's hyperlocal outfit Patch is making 300 of those hires and wondered what it will mean for local news.
— Los Angeles Times media writer James Rainey wrote a piece on the Las Vegas Review-Journal, a newspaper that has poured legal resources into stopping people who use its content without permission. The Times' Mark Milian also provided a quick guide Synthroid Price, to what's OK and what's not when reposting.
— Publish2's Scott Karp wrote an intriguing essay on the concept of a Content Graph, in which media organizations collaborate through distribution to enhance their brand's value.
— News business guru Alan Mutter sensed a theme among news startups — too much focus on news, not enough on business — and wrote a stiff wakeup call.
— Two journalism/tech folks, japan, craiglist, ebay, overseas, paypal, Jeff Sonderman and Michelle Minkoff, wrote a bit about what journalism school is — and isn't — good for. Both are worthwhile reads.
— Finally, British journalism David Higgerson has 10 ideas for building good hyperlocal websites. Most of his (very practical) ideas are useful not just for hyperlocal journalism, but for online news in general.
Similar posts: Cipro No Rx. Buy Flagyl No Prescription. Diflucan Over The Counter. Diflucan results. Diflucan alternatives. Doses Zoloft work.
Trackbacks from: Synthroid Price. Synthroid Price. Synthroid Price. Synthroid schedule. Purchase Synthroid for sale. Synthroid results.
[This review was originally posted at the Nieman Journalism Lab Tramadol No Rx, on June 4, 2010.]
The FTC's ideas for journalism: The U.S. Federal Trade Commission has spent much of the last year listening to suggestions about how they might change antitrust, copyright and tax laws in order to create the best possible climate for good journalism, and this weekend it posted its "discussion draft" of policy proposals to "support the reinvention of journalism." It's a 47-page document, so here's a quick summary of their ideas:
— Expand copyright law to protect news content against online aggregators, including "hot news" legislation, further limits to fair use and mandatory content licenses. Tramadol street price, — Allow antitrust exemptions for news organizations to put up paywalls together and develop a unified system to limit online aggregators.
— Enact direct or indirect government subsidies through a variety of possible means, including a journalism AmeriCorps, more CPB funding, a national local news fund, tax credits to news orgs for employing journalists, university investigative journalism grants, and newspaper and magazine postal subsidies, Tramadol interactions. These subsidies could be paid for through taxes on broadcast spectrum, consumer electronics, advertising, or ISP-cell phone bills.
— Tax code changes to make it easier for news organizations to gain tax-exempt status, Tramadol No Rx.
— Pass various FOIA-related laws to make government data easier to access and search.
It's worth noting that the FTC isn't explicitly endorsing these proposals; the draft reads more as a list of possible proposals that might be worth exploring further. Purchase Tramadol online, Still, j-prof and new media pundit Jeff Jarvis saw a perspective of old-media protectionism running through the draft, as he tore it apart point by point. The FTC is defining journalism through established news organizations and looking to prop them up instead of supporting visionary startups, he wrote. "If the FTC truly wanted to reinvent journalism, the agency would instead align itself with journalism’s disruptors. But there's none of that here." Tramadol No Rx, Jarvis' charges were seconded by two newspapermen, the Washington Examiner's Mark Tapscott and the Los Angeles Times' Andrew Malcolm, who likened the proposals to the government trying to save the auto industry by reviving the gas guzzlers of the 1960s. Steve Buttry of the new Washington news site TBD chimed in, too, online buying Tramadol hcl, homing in on the assertion that newspapers provide the overwhelming majority of our original news.
Free Press' Josh Stearns responded by cautioning against "throwing the baby out with the bath water," noting a few of things that he liked about the FTC's proposals. And at the Huffington Post, Alex Howard praised the FTC's open-government proposals. NYU j-prof Jay Rosen chipped in his own tweet-length proposal for the FTC: "Subsidize universal broadband; fight for sensible net neutrality."
Steve Jobs' pitch for paid news: The folks from the Wall Street Journal's All Things Digital interviewed Apple chief Steve Jobs on stage this week as part of their D8 conference, Tramadol overnight, and Jobs had a few words for the news industry: Yes, he wants to help save journalism, because, as he put it, "“I don’t want to see us descend into a nation of bloggers myself." But if they're going to survive, news organizations should be more aggressive about getting people to pay for content, Jobs said, like Apple did in helping raise e-book prices earlier this year, Tramadol long term.
As it turned out, there was something for everybody to pick apart in that exchange: Ex-Saloner and blogging historian Scott Rosenberg took issue with Jobs' "nation of bloggers" jab, and Steve Safran of the local-news blog Lost Remote said that what Jobs really wants to save is paid, professional journalism, Tramadol No Rx. GigaOm's Mathew Ingram argued that an "iTunes for news" model that Jobs proposed might benefit Jobs, but probably won't work for news outlets. And here at the Lab, Laura McGann pointed out a statement Jobs made elsewhere in the interview that rejected Apple app applicants (sorry, couldn't resist) should simply resubmit their apps, unchanged. Get Tramadol, Meanwhile, we got another diatribe about Apple's app censorship from Advertising Age's Simon Dumenco, and a few other interesting pieces of app news: Statistics showing just how big game apps are on the iPhone and iPad (though content apps aren't doing bad on the iPad), lessons for iPad news apps from Hacks/Hackers' recent app-creating binge, and a cool iPad news reader designed by Stanford students.
To link or not to link?: Author Nicholas Carr, who's about to release a book about how the Internet is hurting our ability to think, highlighting one of the points from that book in a blog post this weekend: The link, where can i cheapest Tramadol online, Carr argues, hurts our ability to concentrate and follow an argument, and in some cases we may be better off without them. Tramadol No Rx, He calls links a high-tech version of the footnote, like little distracting textual gnats buzzing around our heads. "Even if you don't click on a link, your eyes notice it, and your frontal cortex has to fire up a bunch of neurons to decide whether to click or not. You may not notice the little extra cognitive load placed on your brain, but it's there and it matters." Carr approvingly noted a couple of experiments in leaving links to the bottom of articles.
ReadWriteWeb's Marshall Kirkpatrick responded with a thoughtful look at the purpose of links, Order Tramadol from mexican pharmacy, wondering if they really might be better off at the end of articles, and the Columbia Journalism Review's Ryan Chittum was sympathetic to Carr's point as well: "It’s not a trivial question to ask what the Internet is doing to our attention spans," he wrote. "I know mine, for one, is shot to hell."
Carr, who's had his runins with the Internet cognoscenti in the past, predictably caught some flak for his post too, Tramadol without a prescription, including from Mathew Ingram, who argued that links are at least as much an intellectual discipline for the writer as the reader. The Scholarly Kitchen's Kent Anderson noted that links are part of a long academic tradition that includes footnotes and inline citations: "Do they distract. Of course they do, Tramadol No Rx. ... But it’s distraction through addition, if done well." And author Scott Berkun brings up a few variables that others missed, Herbal Tramadol, including the skill of the author, web design, and the "open in new tab" function.
'The Twitter of news': The link-sharing site Digg gave a preview of its new version, which will implement some Twitter-like features and emphasize the news links that the people you follow have shared, rather than just the top overall links. The net effect is an attempt to become, as GigaOm's Liz Gannes put it, buy Tramadol from canada, "the Twitter of news." That, of course, raises the question, "Isn't Twitter already the Twitter of news?" But Digg's advantage, founder Kevin Rose says, is that it does away with the status updates and Justin Bieber memes and gives you purely socially powered links and news.
Tech pioneer Dave Winer was intrigued by the concept, Tramadol maximum dosage, and The Next Web's Zee Kane lauded Digg for integrating more deeply with Twitter. Tramadol No Rx, Alexis Ohanian, co-founder of Reddit, a competitor of Digg's, bashed Rose for "just re-implementing features from other websites," and TechCrunch's Michael Arrington knocked both Rose and Ohanian down a peg in response.
Bidders for Newsweek: Wednesday was The Washington Post Co.'s deadline for formal expressions of interest in buying Newsweek, and it received three offers: OpenGate Capital, a private equity firm that bought TV Guide for $1 in 2008; hedge fund manager and failed Chicago Sun-Times bidder Thane Ritchie; and conservative magazine and website Newsmax. On Twitter, Jeff Jarvis called the bidders "tacky" and wondered whether Newsweek would be better off dead.
Earlier in the week, The New York Times' David Carr offered an explanation for why Newsweek and other magazines seem to be worth so little to potential buyers: "In the current digital news ecosystem, where can i buy cheapest Tramadol online, having 'week' in your title is anachronistic in the extreme, what an investor would call negative equity." At its Tumblr blog, Newsweek responded by arguing that while everyone seems to have the perfect idea of what Newsweek should have done, no one can change the simple business reality that Newsweek is no longer alone in its niche for readers and advertisers.
Reading roundup: A couple of updates on stories from last week, plus a bunch of interesting articles and resources.
— An addendum to last week's Publish2 News Exchange launch: Publish2's Ryan Sholin told the Lab's Megan Garber that it only intends to disrupt the AP, not kill it. The exchange is aimed at the content distribution side of the AP, not the production end, he said. Poynter's Rick Edmonds gave some more explanation of Publish2's plans.
— The New York Times announced it will host Nate Silver's political polling blog FiveThirtyEight, one of the web's top operations at the intersection of data and journalism. Yahoo News' Michael Calderone examined the fact that Silver's been open about his liberal political views and asks how that will work out at the Times.
— Several smart, thought-provoking analyses here: journalism researcher Michele McLellan surveyed online local news publishers, news business expert Alan Mutter looked at Yahoo's hints at a challenge to local newspapers, search guru Danny Sullivan examined a case of traditional media stealing his blog's story; and media analyst Frederic Filloux explained why online advertising is so lousy.
— Finally, a 'why' and a 'how' for a couple of aspects of digital journalism: MediaShift's Roland LeGrand gives journalists the reasons they should learn computer programming, and Poynter's Jeremy Caplan has a great list of tips for crowdsourcing in journalism.
Similar posts: Retin A Dosage. Purchase Zoloft. Armour Over The Counter. Discount Cephalexin. Canada, mexico, india. Zoloft used for.
Trackbacks from: Tramadol No Rx. Tramadol No Rx. Tramadol No Rx. Order Tramadol from United States pharmacy. After Tramadol. Tramadol over the counter.
[This review was originally posted at the Nieman Journalism Lab Diflucan Over The Counter, on May 14, 2010.]
Google's attempt to save the news: There weren't a whole lot of newsy events around journalism to report this week, so we'll start off with the most significant think piece: James Fallows' opus in The Atlantic on Google's efforts to come to the news industry's aid.
Fallows, a veteran journalist and media critic, spent the last year talking to Google engineers and execs about their relationship with the news media, and he came out remarkably optimistic. In a 9, Comprar en línea Diflucan, comprar Diflucan baratos, 000-word piece, Fallows examines the news industry's struggles from Google's perspective, outlines their principles for a way forward — distribution, engagement and monetization — and briefly highlights five of their recent news-oriented projects: Living Stories, Fast Flip, YouTube Direct, online display ads and paid-content logistics, Diflucan cost. He concludes by noting a few of Google's paradoxical stances, which he calls "major and encouraging developments" for the news business:
"The organization that dominates the online-advertising world says that much more online-ad money can be flowing to news organizations. The company whose standard price to consumers is zero says that subscribers can and will pay for news. The name that has symbolized disruption of established media says it sees direct self-interest in helping the struggling journalism business."
Reaction on the piece for future-of-journalism folks ran the gamut, from "absolute must-read" endorsements to groans at the article's years-old concepts. And in a way, both sides are right: To those closely following the journalism-in-tradition scene, there's really no news in this piece, Diflucan Over The Counter. The Google officials' perspectives on why the news is broken and what needs to be done about it are familiar enough to have become conventional wisdom among people thinking about journalism and technology. Diflucan steet value, (Fallows even acknowledges this in a few spots.) But at the same time, Fallows summarizes that relatively new conventional wisdom in a comprehensive, readable way, making the piece a brilliant primer on where the news on the web stands right now. For the insider, this is ho-hum stuff; for everyone else, this is an ideal introduction to the subject.
Journalism prof and digital media expert Jeff Jarvis, who's written his own book on Google, is Diflucan addictive, is in the 'must-read' camp, citing Fallows' impressions as evidence that Google is a friend to the news business. Jason Fry and All Things Digital's Peter Kafka are more skeptical, questioning Google's ability to actually turn the industry around.
Fry notes that publishers are unorganized and tentative, making industry-wide solutions difficult to implement, Where can i cheapest Diflucan online, and Kafka says that even with Google's help, online ads aren't likely to be valuable enough to support substantive newsgathering. The Awl's Choire Sicha makes a similar point, while using Google's statistics to point out the folly of news organizations' editorial cuts over the past few years.
Mediocre reviews for iPad apps Diflucan Over The Counter, : It's been a month and a half now since the iPad was released, and we're starting to get beyond the "first impressions" phase of the reviews of news organizations' iPad apps. News business guru Alan Mutter combed through the reviews and ratings at Apple's app store to evaluate the 10 most popular news apps, and found that apps by European outlets and broadcasters are most well-liked, and pay apps aren't too popular, buy generic Diflucan.
If you want to succeed on the iPad, he said, you have to go beyond the look and feel of your legacy product and offer some more value, especially if you're going to charge: "Consumers are smart enough to tell when a publisher slaps a premium price on recycled print or web content – and they won’t go for it."
Usability expert Jakob Nielsen took a more thorough look at iPad apps, releasing a 93-page report on a few dozen apps from media companies and elsewhere. About Diflucan, His summary is pretty illuminating: He found that designers have tried to outdo themselves with clever interaction techniques, leading to a whole lot of confusion about how to navigate apps. (New York Times designer Alexis Lloyd disagreed with Nielsen's emphasis on simplicity, arguing that experimentation is more important right now.) Nielsen also concluded, like Mutter, that designers are relying too much on a print-based concept revolving around the "next article" idea, which he argued doesn't make sense on mobile media, Diflucan images.
After fiddling around with the iPad for a few weeks, the Lab's Jason Fry discovered that the iPad's killer app may not be its apps at all, but instead its lightning-fast, easy-to-use browser, Diflucan Over The Counter. That might put news orgs in an awkward spot, Fry wrote, after hanging their hats on apps: They still can't compete with their own (free) websites on the iPad.
Dissecting Newsweek's downfall: Commentary continued to roll in on last week's news that The Washington Post Co. will try to sell Newsweek, Buy cheap Diflucan no rx, starting with a column by Newsweek's editor, Jon Meacham. He defended the magazine against its doomsayers, pointed out that it hasn't closed and arguing that if the economic climate were better, it would be profitable. Diflucan Over The Counter, He also made a case for Newsweek's continued existence, saying it "means something to the country" and represents an opportunity to bring a large number of otherwise fragmented Americans together to focus on common topics. The magazine's task now, he wrote, online buying Diflucan, was to find a business model to sustain that role. (Journalism prof Jay Rosen was not impressed.)
Others continued to chime in with their opinions about why Newsweek failed: Blogging pioneer Dave Winer said it was a lack of innovation stemming from a corporate mindset, and Harvard Business Review writer (and former Newsweek staffer) Dan McGinn said the demise of U.S. News & World Report as a rival hurt, too. Buy Diflucan from canada, Forbes' Trevor Butterworth and blogger Greg Satell both hit on a different idea: There was no there there. Butterworth made a striking comparison of the amount of content in an issue of Newsweek and the Economist, and Satell compared Newsweek with Foreign Affairs and the Atlantic, two magazines whose upscale readership Meacham has coveted. "The notion that offering a magazine consisting mainly of one-page opinion pieces would attract a better quality audience than reporting flies in the face of any apparent media reality," Satell wrote, Diflucan Over The Counter.
Meanwhile, the discussion of possible buyers began to build. Yahoo's Michael Calderone shot down media moguls Rupert Murdoch, Philip Anschutz and Carlos Slim Helu as options and raised the possibility of a bid by Michael Bloomberg. A few days later, The New York Observer revealed that Thomson Reuters and Politico owner Allbritton Communications were interested, order Diflucan online c.o.d, and The Wall Street Journal reported that Univision owner and billionaire investor Haim Saban is interested, too.
Facebook privacy fury builds: An update on the ongoing consternation over Facebook's latest privacy breach: IBM developer Matt McKeon and The New York Times' Guilbert Gates provided striking visual depictions of Facebook's advances against privacy and the hoops its users have to jump through to maintain it. Facebook (sort of) answered users' privacy questions at The New York Times and held an internal meeting Diflucan Over The Counter, about privacy Thursday.
But the cries about privacy violations continue unabated. GigaOm's Liz Gannes said Facebook's Times Q&A wasn't sufficiently conciliatory, and All Facebook called for Instant Personalization to become opt-in, Diflucan reviews, rather than opt-out. Others went further, quitting Facebook and calling for an open alternative. Four NYU students were happy to oblige them, becoming almost literally an overnight sensation and raising $100,000 this week for a decentralized Facebook alternative called Diaspora* on the back of a New York Times profile and plenty of tech-blog hype.
Jeff Jarvis offered a smart analysis of why Facebook is rubbing so many people the wrong way: It's confusing the public sphere (the type of public we usually think of when we think of the word "public") with the "publics" we create for ourselves when we build networks of our friends and family on Facebook.
Jarvis explains the difference well: "When I blog something, canada, mexico, india, I am publishing it to the world for anyone and everyone to see: the more the better, is the assumption. But when I put something on Facebook my assumption had been that I was sharing it just with the public I created and control there. That public is private."
Reading roundup: A few quick hits on pieces you should make sure to catch this week:
— The Wall Street Journal is one of the first newspapers to try to do some significant location-based news innovation with Foursquare, and the Lab's Megan Garber has a good overview of what they have going, Diflucan Over The Counter.
— The Huffington Post turned five this week, and The Columbia Journalism Review put together five reflections on its impact to mark the occasion. CJR also published a lengthy examination of the state of nonprofit investigative journalism, Kjøpe Diflucan på nett, köpa Diflucan online, focusing on California Watch and The Center for Public Integrity.
— Columbia professor Michael Schudson, who co-authored a major study of the state of journalism published last fall, talked some more about several aspects of "the new news ecosystem" in a Q&A with The Common Review.
— Finally, a piece I missed last week: Longtime Salon writer Scott Rosenberg gave a speech at a Stanford conference that thoughtfully delineates a 21st-century definition of journalism. Here's the one-sentence version: "You’re doing journalism when you’re delivering an accurate and timely account of some event to some public.".
Similar posts: Glucophage Mg. Retin A For Sale. Flagyl Over The Counter. Retin A mg. Discount Cipro. Buy Zoloft online cod.
Trackbacks from: Diflucan Over The Counter. Diflucan Over The Counter. Diflucan Over The Counter. Kjøpe Diflucan på nett, köpa Diflucan online. About Diflucan. Ordering Diflucan online.